L. Roy Papp & Associates’s CVS Health CVS Stock Holding History

L. Roy Papp & Associates’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,018	Closed	-$317K	–	181
2023 Q4	$317K	Hold	4,018	–	–	0.04%	142
2023 Q3	$281K	Hold	4,018	–	–	0.04%	142
2023 Q2	$278K	Hold	4,018	–	–	0.04%	147
2023 Q1	$299K	Hold	4,018	–	–	0.04%	147
2022 Q4	$374K	Sell	4,018 -80	-2%	-$7.72K	0.05%	135
2022 Q3	$391K	Hold	4,098	–	–	0.06%	125
2022 Q2	$380K	Buy	4,098 +80	+2%	+$7.81K	0.06%	134
2022 Q1	$407K	Sell	4,018 -17	-0.4%	-$1.79K	0.05%	138
2021 Q4	$416K	Buy	4,035 +17	+0.4%	+$1.57K	0.05%	141
2021 Q3	$341K	Hold	4,018	–	–	0.04%	151
2021 Q2	$335K	Buy	4,018 +985	+32%	+$80.7K	0.04%	151
2021 Q1	$228K	Buy	+3,033	New	+$221K	0.03%	162
2017 Q4	–	Sell	-4,179	Closed	-$340K	–	150
2017 Q3	$340K	Sell	4,179 -2,170	-34%	-$172K	0.07%	106
2017 Q2	$511K	Sell	6,349 -7,399	-54%	-$584K	0.11%	104
2017 Q1	$1.08M	Sell	13,748 -4,034	-23%	-$322K	0.25%	70
2016 Q4	$1.4M	Sell	17,782 -1,322	-7%	-$107K	0.32%	66
2016 Q3	$1.7M	Buy	19,104 +3,480	+22%	+$328K	0.39%	59
2016 Q2	$1.5M	Buy	15,624 +7,633	+96%	+$761K	0.35%	63
2016 Q1	$829K	Buy	+7,991	New	+$777K	0.2%	90

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

L. Roy Papp & Associates's CVS Position: Q1 2024 in Review

L. Roy Papp & Associates sold out of CVS Health (CVS) in Q1 2024, closing a stake of 4,018 shares — an estimated $317K sold.

L. Roy Papp & Associates first reported a position in CVS in Q1 2016 and held it in 19 quarters. The position peaked at $1.7M in Q3 2016. 2,182 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

L. Roy Papp & Associates reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
L. Roy Papp & Associates sold 4,018 CVS Health shares in Q1 2024, an estimated $317K.
L. Roy Papp & Associates first reported a position in CVS Health in Q1 2016 and held it in 19 quarters.
L. Roy Papp & Associates's CVS Health position peaked at $1.7M in Q3 2016.
2,182 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on L. Roy Papp & Associates's 13F filing for Q1 2024, filed 15 Apr 2024.